Publications by authors named "A J Pateman"

We previously reported short-term outcomes for stenting of aortic coarctation (CoA) (native or re-coarctation) with newer generation low-profile stents (Valeo, Formula, and Begraft stents) in children under 30 kg. We present here the medium-term outcomes of this procedure. Retrospective review of patients weighing under 30 kg who had percutaneous stent treatments for coarctation between 2012 and 2021 was performed.

View Article and Find Full Text PDF

Although Li-air rechargeable batteries offer higher energy densities than lithium-ion batteries, the insulating LiO formed during discharge hinders rapid, efficient re-charging. Redox mediators are used to facilitate LiO oxidation; however, fast kinetics at a low charging voltage are necessary for practical applications and are yet to be achieved. We investigate the mechanism of LiO oxidation by redox mediators.

View Article and Find Full Text PDF

The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the former series were addressed in the later, delivering a robust candidate for progression towards clinical studies.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on designing and synthesizing new factor Xa inhibitors that are based on sulfonamidopyrrolidin-2-one structures with specific chemical motifs.
  • The resulting compounds showed strong anticoagulant effects and favorable oral pharmacokinetics, meaning they are effective when taken by mouth.
  • A concern with the aminoindane series was their significant inhibition of the P450 enzyme over time, while the phenylpyrrolidine series did not have this issue, making it more promising for once-daily dosing in humans.
View Article and Find Full Text PDF

Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa inhibitors, incorporating neutral and basic monoaryl P4 groups, ultimately producing potent inhibitors with effective levels of anticoagulant activity and extended oral pharmacokinetic profiles. However, time dependant inhibition of Cytochrome P450 3A4 was a particular issue with this series.

View Article and Find Full Text PDF